Allarity Therapeutics, Inc.Pembelian
ALLR
BULLISH, It's supper undervalued. $19-$20 cash on hand, 1 million float, 1.4 million O/S, The company confirmed there will be zero need to dilute via ATM offering. They recently got granted EPO patent, FDA news should be out very soon.
2 gaps need to filled on the way up, keep an eye on it. with $19-$20 million cash on hand, a price target of $10 is fairly valued even without FDA granted.
2 gaps need to filled on the way up, keep an eye on it. with $19-$20 million cash on hand, a price target of $10 is fairly valued even without FDA granted.
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.